Nasopharyngeal carcinoma with paranasal sinus invasion: the prognostic significance and the evidence-based study basis of its T-staging category according to the AJCC staging system
© Tian et al.; licensee BioMed Central Ltd. 2014
Received: 8 February 2014
Accepted: 30 October 2014
Published: 18 November 2014
To evaluate the prognostic significance of paranasal sinus invasion for patients with NPC and to provide empirical proofs for the T-staging category of paranasal sinus invasion according to the AJCC staging system for nasopharyngeal carcinoma.
The clinical records and imaging studies of 770 consecutive patients with newly diagnosed, untreated, and nondisseminated NPC were reviewed retrospectively. The overall survival, distant metastasis-free survival, and local relapse-free survival of these patients were analyzed using the Kaplan-Meier method, and the differences were compared using the log-rank test.
The incidence of paranasal sinus invasion was 23.6%, with the rate of incidence of sphenoid sinus invasion being the highest. By multivariate analysis, paranasal sinus invasion was shown to be an independent prognostic factor for overall survival, distant metastasis-free survival, and local relapse-free survival (p < 0.05 for all). No significant differences in overall survival, distant metastasis-free survival, and local relapse-free survival were observed between patients with sphenoid sinus invasion alone and those with maxillary sinus and ethmoid sinus invasion (p = 0.87, p = 0.80, and p = 0.37, respectively). The overall survival, distant metastasis-free survival, and local relapse-free survival for patients with stage T3 disease with paranasal sinus invasion were similar to the survival rates for patients with stage T3 disease without paranasal sinus invasion (p = 0.22, p = 0.15, and p = 0.93, respectively). However, the rates of overall survival and local relapse-free survival were better for patients with stage T3 disease with paranasal sinus invasion than for patients with stage T4 disease (p < 0.01, and p = 0.03, respectively).
Paranasal sinus invasion is an independent negative prognostic factor for NPC, regardless of which sinus is involved. Our results confirm that it is scientific and reasonable for the AJCC staging system for nasopharyngeal carcinoma to define paranasal sinus invasion as stage T3 disease.
KeywordsNasopharyngeal carcinoma Paranasal sinus Invasion Prognosis Staging
Nasopharyngeal carcinoma (NPC) is endemic in Southeast Asia, especially in the southern provinces of China . The occurrence of paranasal sinus invasion is not unusual, with an incidence of nearly 30% based on CT and MRI findings . Sphenoid sinus invasion is the most common, followed by maxillary sinus and ethmoid sinus invasion.
The tumor-node-metastasis (TNM) staging system for malignancies is used to evaluate prognosis, aid treatment planning, and facilitate the stratification of treatment. At present, the seventh edition of the American Joint Committee on Cancer (AJCC) staging system is widely used throughout the world, and patients with NPC and paranasal sinus invasion are defined as stage T3 according to the staging system . With regard to the prognostic value of paranasal sinus invasion and its suitable position in the T staging, there are few literature reports for reference. Tao et al. developed a prognostic scoring system (PSS) that could help identify NPC patients with different risk for locoregional relapse, and found that sphenoid sinus, ethmoid sinus and maxillary sinus invasion were classified as different risk groups . While Mao et al. considered sphenoidal sinus invasion alone had a better outcome for patients with NPC than did other paranasal sinus invasion . Both studies indicated that tumor invasion into the different paranasal sinuses might have different effects on the prognosis of patients with NPC. On the other hand, the results of Pan et al. revealed that when paranasal sinus invasion were classified as T3 according the 7th edition AJCC T classification, the segregation of LRFS curves between stage T3 and T4 groups could be well displayed . Which, in a sense, have provided evidence and reference for the AJCC T- staging.
In the present staging system for NPC, radiologic imaging, especially MRI, plays an important role. In comparison to CT, MRI, with its superior soft-tissue contrast, can provide a more accurate definition of early invasion beyond the nasopharynx and a more accurate assessment of the parapharyngeal space, skull base, paranasal sinus, and cranial nerve invasion [7–9]. Given these advantages, MRI is considered the optimal imaging technique for studying the extension of local disease in NPC.
Therefore, we conducted a retrospective study with a large sample size to evaluate the prognostic significance of paranasal sinus invasion for patients with NPC and its suitable position in the T classification, and thus to provide more empirical proofs for the AJCC staging system.
The characteristics of 770 patients with nasopharyngeal carcinoma
Number of patients(%)
≥50 years old
<50 years old
IVA ~ IVB
MR imaging protocol and image assessment
All patients underwent MR imaging with a 1.5-T system (Signa CV/i; GE Healthcare, Chalfont St Giles, England). The region from the suprasellar cistern to the inferior margin at the sternal end of the clavicle was examined with a head-and-neck coil. T1-weighted, fast spin-echo images in the axial, coronal, and sagittal planes (repetition time msec/echo time msec, 500–600/10–20) and T2-weighted, fast spin-echo MR images in the axial plane (4000–6000/95–110) were obtained before the injection of contrast material. After intravenous administration of gadopentetate dimeglumine (Magnevist; Schering, Berlin, Germany) at a dose of 0.1 mmol per kilogram of body weight, the axial and sagittal T1-weighted spin-echo sequences and coronal T1-weighted fat-suppressed spin-echo sequences were performed sequentially using the same parameters applied prior to the injection of gadopentetate dimeglumine. A section thickness of 5 mm, an intersection gap of 1 mm and a matrix of 512 × 512 were used.
All patients were treated with definitive-intent radiation therapy. A total of 618 of the 770 patients (80.2%) underwent two-dimensional conventional radiation therapy, 115 (14.9%) underwent intensity-modulated radiation therapy (IMRT), and 37 (4.8%) underwent three-dimensional conformal radiation therapy. Details regarding the radiation therapy techniques have been reported previously [11–13].
Of the 416 patients with stage III or IV NPC (classified as stage T3-T4 and/or stage N2-N3), 370 (89%) received neoadjuvant, concomitant, or adjuvant chemotherapy. When possible, salvage treatments, including afterloading, surgery, and chemotherapy, were provided in the event of documented relapse or if the disease persisted.
The follow-up period was estimated from the first day of treatment to either the day of death or the day of the last examination. Follow up was performed with imaging or clinical assessment. The patients were evaluated at least once every three months during the first two years; thereafter, patients were followed up every six months until death.
The Statistical Package for Social Sciences 15.0 (SPSS, Chicago, IL) was used for statistical analysis. The following endpoints (interval to the first defining event) were assessed: overall survival (OS), distant metastasis-free survival (DMFS), and local relapse-free survival (LRFS).The actual rates were calculated using the Kaplan-Meier method, and the differences were compared with the log-rank test . Multivariate analyses with the Cox proportional hazards model were used to test independent significance by the backward elimination of insignificant explanatory variables . The criterion for statistical significance was set at α = 0.05, and p values were based on two-sided test results.
Incidence of paranasal sinus invasion
The incidence of paranasal sinus invasion was 23.6% (182 of 770 patients), with invasion of the sphenoid sinus, maxillary sinus and ethmoid sinus in 162 (21.0%), 86 (11.2%) and 38 (4.9%) of the 770 patients, respectively. None of the patients had frontal sinus invasion. The incidence of sphenoid sinus invasion was higher than that of maxillary sinus and ethmoid sinus invasion in patients with NPC. Of the 162 patients with sphenoid sinus invasion, 89 (54.9%) did not have maxillary sinus and ethmoid sinus invasion. In contrast, of the 86 patients with maxillary sinus invasion and 38 patients with ethmoid sinus invasion, 69 (80.2%) and 32 (84.2%) also had sphenoid sinus invasion, respectively. Of the 182 patients with paranasal sinus invasion, 97 (53.3%) had stage T3 disease, and 85 (46.7%) had stage T4 disease.
Prognosis of patients with paranasal sinus invasion
The median follow-up period was 84 months (range, 3–120 months). In total, 59 patients (7.6%) developed local-regional failure, 129 patients (16.8%) developed distant metastases, and 184 patients (23.9%) died. The 5-year overall survival, distant metastasis-free survival, and local relapse-free survival rates for the entire patient population were 80.2%, 84.7%, and 92.4%, respectively. Significant differences were observed between patients without and with paranasal sinus invasion in overall survival (84.4% vs 67.2%, P < 0.01), distant metastasis-free survival (88.4% vs 72.3%, P < 0.01) and local relapse-free survival (94.0% vs 87.0%, P < 0.01), with better outcomes associated with patients without paranasal sinus invasion.
Multivariate analysis of prognostic factors for patients with nasopharyngeal carcinoma
Endpoint and Variable
Odds Ratio (95% confidence interval)
Paranasal sinus involvement
Parapharyngeal space extension
Distant metastasis-free survival
Paranasal sinus involvement
Parapharyngeal space extension
Skull base erosion
Local relapse-free survival
Paranasal sinus involvement
T-staging category of paranasal sinus invasion
The incidence of paranasal sinus invasion of patients with NPC
NPC is an aggressive neoplasm, and the spread of the tumor into the paranasal sinuses occurs relatively frequently. The result of the present study, based on the data from a large cohort, suggested that the incidence of the invasion of the paranasal sinus in patients with NPC was 23.6%. The highest rate of incidence was of sphenoid sinus invasion (21%), followed by maxillary sinus invasion (11.2%) and ethmoid sinus invasion (4.9%). Chong et al. reported the CT and MRI findings of 114 patients with NPC, 21%, 9% and 4% of those patients were detected with sphenoid sinus, maxillary sinus and ethmoid sinus invasion, respectively . While the results of King et al. showed that the incidence rates of sphenoid sinus, maxillary sinus and ethmoid sinus invasion were 27%, 5% and 14%, respectively . Our results are roughly the same as those of Chong et al., but a little different from those of King et al. For patients with NPC, the local disease spreads in a stepwise manner from proximal to distal sites . Tumors of the roof of the nasopharynx tend to spread directly and superiorly into the skull base, where there is no muscle or fascia to act as a barrier against tumor invasion, as well as to the floor of the sphenoid sinus, which borders the nasopharynx roof. Therefore, for most patients with NPC, the primary tumor originating from the nasopharynx directly destroys the floor of the sphenoid sinus. This accounts for the high rate of incidence of sphenoid sinus invasion. Additionally, the posterior wall of the maxillary sinus is adjacent to the pterygopalatine fossa and accordingly, tumors extending anteriorly to the pterygopalatine fossa can easily spread to the maxillary sinus. In contrast, tumors extending to the sphenoid sinus or nasal cavity are likely to invade the ethmoid sinus anteriorly or superiorly.
The prognostic significance of paranasal sinus invasion for patients with NPC
Our retrospective study, based on large number of cases, revealed that the invasion of the paranasal sinus was an independent negative prognostic factor for overall survival, distant metastasis-free survival, and local relapse-free survival in patients with NPC. Hence, it is scientific and reasonable for paranasal sinus invasion to be included in the AJCC staging system. Some researchers proposed that the maximum primary tumor diameter (MPTD) or primary tumor volume (PTV) had some effect on the prognosis of patients with NPC [17–21]. Due to the proximity of the floor of the sphenoid sinus to the roof of the nasopharynx, and the majority of patients with maxillary sinus or ethmoid sinus invasion accompanied with sphenoid sinus invasion simultaneously, we had speculated that the primary tumor volume of patients with sphenoid sinus invasion might be a little smaller than that of patients with ethmoid sinus and maxillary sinus invasion, making for somewhat better prognosis for patients. However, the results showed that the prognostic significances for both groups were not significantly different. We speculate this may be due to the following reasons. First, the primary treatment modality for patients with NPC was radiation therapy. With the aid of MRI, the range of local lesions could be evaluated with greater accuracy and the target and field could be designed more rationally . Additionally, the improved treatment strategies for T3-4 patients with NPC, including the boost technique of two-dimensional radiation therapy, IMRT, and the combination of chemotherapy with radiotherapy, have dramatically improved the treatment outcome with respect to loco-regional control [12, 23, 24]. This may be the reason why no difference was observed in the LRFS between patients with sphenoid sinus invasion alone and those with maxillary sinus and ethmoid sinus invasion. Second, as for the DMFS rate, we think the possible reason may lie in the fact that the difference of the tumor volume resulted from the different paranasal sinus invasion may not be significant enough to lead to significant difference of risks for distant failure. For the reasons given above, it is reasonable to consider paranasal sinus invasion as a single entity in the TNM classification, regardless of which sinus is involved.
The evidence-based study basis of T-staging category of paranasal sinus invasion
In the fifth edition of the AJCC staging system for NPC, patients with paranasal sinus invasion were defined as T3, and this classification remains in the sixth and the current seventh edition of the AJCC staging system. While paranasal sinus invasion is classified as stage T4 disease according to the Chinese 2008 staging system . Pan et al. compared the predictive value of both staging systems for patients with NPC . The results revealed that for the Chinese 2008 T classification, the 5-year LRFS rates of T3 and T4 groups did not differ significantly, while the rates between both groups were remarkably different according to the 7th edition AJCC T classification. The possible reason lie in that when compared to cranial nerve palsy and intracranial extension, paranasal sinus invasion maybe occur a little bit earlier, accordingly, the tumor volume may be somewhat smaller, which possibly makes for a better prognosis. In a sense, this study demonstrated that it was more suitable for paranasal sinus invasion to be classified as stage T3. Our results, based on a large number of samples, further confirmed this viewpoint, providing more empirical proofs for the rationality of the AJCC T staging.
The influence of MRI on patients with NPC
All of the patients in the current study were evaluated by MRI. For the lesions of the paranasal sinus in patients with NPC, many inflammatory changes overlapped with the neoplastic process, and it is important to differentiate between the two entities and to define the inflammation-tumor border. MR imaging, especially T2-weighted and contrast enhanced MR, can help us to solve this challenging problem. The inflammatory lesions usually present high signal intensity on T2-weighted image and a thin superficial enhancement after contrast administration, while the tumors reveal relatively lower signal intensity on T2-weighted image and solid enhancement with contrast administration. In addition, most importantly, the signal intensity and enhancement pattern of tumors invading the paranasal sinus are usually in accordance with those of the primary tumor of the nasopharynx [2, 26, 27]. Over the past several decades, MRI has been used to assess the extent of NPC more reliably and accurately compared with CT, which has been shown to influence the stage assignment and disease prognosis [28–30].
Limitations of this study
It should be stressed that because of limited resources, most of patients (80.2%) in this study were treated with conventional radiotherapy technique. Recently, intensity-modulated radiotherapy (IMRT) has gradually replaced two-dimensional conventional radiotherapy as the primary radiotherapy technique for NPC and has been reported to provide encouraging treatment outcome [31–35]. Therefore, the suitability of the staging system of NPC amid the changes in therapeutic methods needs continual assessment. As well, the effect of paranasal sinus invasion on the prognosis and staging of patients with NPC should be further confirmed by clinic studies.
Paranasal sinus invasion is an independent negative prognostic factor for NPC, regardless of which sinus is involved. It is scientific and reasonable for paranasal sinus invasion to be defined as stage T3 disease, as proposed in the AJCC staging system. Our study provided some empirical proofs for the AJCC T staging.
The study was granted from the National Natural Science Foundation of China(No. 30371620), and Sci-Tech Research Foundation of Guangzhou City (No.2008JI-C141-3).
- Gu MF, Liu LZ, He LJ, Yuan WX, Zhang R, Luo GY, Xu GL, Zhang HM, Yan CX, Li JJ: Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma. Int J Cancer. 2013, 132: 215-223. 10.1002/ijc.27638.View ArticlePubMedGoogle Scholar
- Chong VF, Fan YF, Khoo JB: Computed tomographic and magnetic resonance imaging findings in paranasal sinus invasion in nasopharyngeal carcinoma. Ann Acad Med Singapore. 1998, 27: 800-804.PubMedGoogle Scholar
- Edge SB, Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010, 17: 1471-1474. 10.1245/s10434-010-0985-4.View ArticlePubMedGoogle Scholar
- Tao CJ, Liu X, Tang LL, Mao YP, Chen L, Li WF, Yu XL, Liu LZ, Zhang R, Lin AH, Ma J, Sun Y: Prognostic scoring system for locoregional control among the patients with nasopharyngeal carciinoma treated by intensity-modulated radiotherapy. Chin J Cancer. 2013, 32: 494-501. 10.5732/cjc.013.10121.View ArticlePubMedPubMed CentralGoogle Scholar
- Mao YP, Hong MH, Sun Y, Liang SB, Li L, Liu LZ, Tang LL, Cao SM, Lin AH, Lu TX, Liu MZ, Ma J: Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system. Ai Zheng. 2007, 26: 1099-1106. [Article in Chinese]PubMedGoogle Scholar
- Pan J, Xu Y, Qiu S, Zong J, Guo Q, Zhang Y, Lin S, Lu JJ: A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma. Am J Clin Oncol. 2013, Epub ahead of printGoogle Scholar
- Liang SB, Sun Y, Liu LZ, Chen Y, Chen L, Mao YP, Tang LL, Tian L, Lin AH, Liu MZ, Li L, Ma J: Extension of local disease in nasopharyngeal carcinoma detected by magnetic resonance imaging: improvement of clinical target volume delineation. Int J Radiat Oncol Biol Phys. 2009, 75: 742-750. 10.1016/j.ijrobp.2008.11.053.View ArticlePubMedGoogle Scholar
- King AD, Vlantis AC, Bhatia KS, Zee BC, Woo JK, Tse GM, Chan AT, Ahuja AT: Primary nasopharyngeal carcinoma: diagnostic accuracy of MR imaging versus that of endoscopy and endoscopic biopsy. Radiology. 2011, 258: 531-537. 10.1148/radiol.10101241.View ArticlePubMedGoogle Scholar
- Liao XB, Mao YP, Liu LZ, Tang LL, Sun Y, Wang Y, Lin AH, Cui CY, Li L, Ma J: How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography?. Int J Radiat Oncol Biol Phys. 2008, 72: 1368-1377. 10.1016/j.ijrobp.2008.03.017.View ArticlePubMedGoogle Scholar
- Chen LS, Wei GY, Hu XF, Zeng XH, Lu QX: Study of MR image for invasion of paranasal sinuses in 56 cases with nasopharyngeal carcinoma. Chin Ger J Clin Oncol. 2009, 8: 719-721. 10.1007/s10330-009-0133-4.View ArticleGoogle Scholar
- Luo W, Deng X-W, Lu T-X: Dosimetric evaluation for three dimensional radiotherapy plans for patients with early nasopharyngeal carcinoma. Ai Zheng. 2004, 23: 605-608. [in Chinese]PubMedGoogle Scholar
- Zhao C, Han F, Lu LX, Huang SM, Lin CG, Deng XW, Lu TX, Cui NJ: Intensity modulated radiotherapy for local-regional advanced asopharyngeal carcinoma. Ai Zheng. 2004, 23: 1532-1537. [in Chinese]PubMedGoogle Scholar
- Ma J, Liu L, Tang L, Zong J, Lin A, Lu T, Cui N, Cui C, Li L: Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma: prognostic value and staging categories. Clin Cancer Res. 2007, 13: 1445-1452. 10.1158/1078-0432.CCR-06-2059.View ArticlePubMedGoogle Scholar
- Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53: 457-481. 10.1080/01621459.1958.10501452.View ArticleGoogle Scholar
- Cox DR: Regression models and life tables. J R Stat Soc Series B Stat Methodol. 1972, 34: 187-220.Google Scholar
- King AD, Lam WW, Leung SF, Chan YL, Teo P, Metreweli C: MRI of local disease in nasopharyngeal carcinoma: tumour extent vs tumour stage. Br J Radiol. 1999, 72: 734-741. 10.1259/bjr.72.860.10624338.View ArticlePubMedGoogle Scholar
- Liang SB, Deng YM, Zhang N, Lu RL, Zhao H, Chen HY, Li SE, Liu DS, Chen Y: Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma. BMC Cancer. 2013, 13: 260-267. 10.1186/1471-2407-13-260.View ArticlePubMedPubMed CentralGoogle Scholar
- Lee CC, Ho HC, Lee MS, Hsiao SH, Hwang JH, Hung SK, Chou P: Primary tumor volume of nasopharyngeal carcinoma: significance for survival. Auris Nasus Larynx. 2008, 35: 376-380. 10.1016/j.anl.2007.10.010.View ArticlePubMedGoogle Scholar
- Wu Z, Zeng RF, Su Y, Gu MF, Huang SM: Prognostic significance of tumor volume in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy. Head Neck. 2013, 35: 689-694. 10.1002/hed.23010.View ArticlePubMedGoogle Scholar
- Shen C, Lu JJ, Gu Y, Zhu G, Hu C, He SC: Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy. Larynnoscope. 2008, 18: 1206-1210.View ArticleGoogle Scholar
- Chen C, Fei Z, Pan J, Bai P, Chen L: Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Jpn J Clin Oncol. 2011, 41: 537-542. 10.1093/jjco/hyq242.View ArticlePubMedGoogle Scholar
- Chen L, Liu LZ, Mao YP, Tang LL, Sun Y, Chen Y, Lin AH, Li L, Ma J: Grading of MRI-detected skull-base invasion in nasopharyngeal carcinoma and its prognostic value. Head Neck. 2011, 33: 1309-1314. 10.1002/hed.21606.View ArticlePubMedGoogle Scholar
- Liu L, Liang S, Li L, Mao Y, Tang L, Tian L, Liao X, Cui C, Lin A, Ma J: Prognostic impact of magnetic resonance imaging-detected cranial nerve invasion in nasopharyngeal carcinoma. Cancer. 2009, 115: 1995-2003. 10.1002/cncr.24201.View ArticlePubMedGoogle Scholar
- Ma J, Mai HQ, Hong MH, Min HQ, Mao ZD, Cui NJ, Lu TX, Mo HY: Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol. 2001, 19: 1350-1357.PubMedGoogle Scholar
- Committee of Chinese Clinical Staging of Nasopharyngeal Carcinoma: Report on the revision of nasopharyngeal carcinoma '92 staging. Chin J Radiat Oncol. 2009, 18: 2-6. [in Chinese]Google Scholar
- Lanzieri CF, Shah M, Krauss MD, Lavertu PL: Use of gadoliniumenhanced MR imaging for differentiating mucoceles from neoplasms in the paranasal sinuses. Radiology. 1991, 178: 425-428. 10.1148/radiology.178.2.1987603.View ArticlePubMedGoogle Scholar
- Som PM, Shapiro MD, Biller HF, Sasaki C, Lawson W: Sinonasal tumors and inflammatory tissues: differentiation with MRI. Radiology. 1988, 167: 803-807. 10.1148/radiology.167.3.3363145.View ArticlePubMedGoogle Scholar
- Chung NN, Ting LL, Hsu WC, Lui LT, Wang PM: Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head Neck. 2004, 26: 241-246. 10.1002/hed.10378.View ArticlePubMedGoogle Scholar
- Abdel Khalek Abdel Razek A, King A: MRI and CT of nasopharyngeal carcinoma. AJR Am J Roentgenol. 2012, 198: 11-18. 10.2214/AJR.11.6954.View ArticlePubMedGoogle Scholar
- Lee AW, Sze WM, Au JS, Leung SF, Leung TW, Chua DT, Zee BC, Law SC, Teo PM, Tung SY, Kwong DL, Lau WH: Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005, 61: 1107-1116. 10.1016/j.ijrobp.2004.07.702.View ArticlePubMedGoogle Scholar
- Sun Y, Tang LL, Chen L, Li WF, Mao YP, Liu LZ, Lin AH, Li L, Ma J: Promising treatment outcomes of intensity modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system. BMC Cancer. 2012, 12: 68-10.1186/1471-2407-12-68.View ArticlePubMedPubMed CentralGoogle Scholar
- Tham IW, Hee SW, Yeo RM, Salleh PB, Lee J, Tan TW, Fong KW, Chua ET, Wee JT: Treatment of nasopharyngeal carcinoma using intensity modulated radiotherapy-the national cancer centre Singapore experience. Int J Radiat Oncol Biol Phys. 2009, 75: 1481-1486. 10.1016/j.ijrobp.2009.01.018.View ArticlePubMedGoogle Scholar
- Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, Akazawa P, Weinberg V, Fu KK: Intensity modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002, 53: 12-22. 10.1016/S0360-3016(02)02724-4.View ArticlePubMedGoogle Scholar
- Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT: Treatmentofnasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004, 60: 1440-1450. 10.1016/j.ijrobp.2004.05.022.View ArticlePubMedGoogle Scholar
- Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ: Intensity modulated radiation therapy (IMRT)for nasopharynx cancer: update of the Memorial Sloan-Ketteringexperience. Int J Radiat Oncol Biol Phys. 2006, 64: 57-62. 10.1016/j.ijrobp.2005.03.057.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/14/832/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.